Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Ann Arbor-based RetroSense Begins Human Trials for Blindness Cure

Thursday, March 24, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

RetroSense Therapeutics, an Ann Arbor-based biomedical startup has begun human trials for a drug it's designed that could restore sight to the blind, according to a report by Crain's Business Detroit.


Read more.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal